Trial Outcomes & Findings for Ultrasound to Verify Lung-isolation During Single-lung Ventilation (NCT NCT03729999)

NCT ID: NCT03729999

Last Updated: 2024-12-31

Results Overview

Ultrasound will be used to look for lung sliding in the ventilated lung field and lack of lung sliding and presence of lung pulse on the operative/isolated lung field. The effectiveness of this modality will also be compared to the lung auscultation for assessing lung isolation, which along with FOB is the current accepted standards of care.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

40 participants

Primary outcome timeframe

Within 5 minutes of intubation and single lung ventilation device placement

Results posted on

2024-12-31

Participant Flow

Participant milestones

Participant milestones
Measure
Ultrasonography
Patients requiring single lung ventilation for a surgical procedure will have a bedside ultrasound to evaluate lung isolation. Portable, Point-of-Care Ultrasound: Portable ultrasonography done at the bedside.
Overall Study
STARTED
40
Overall Study
COMPLETED
40
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Ultrasound to Verify Lung-isolation During Single-lung Ventilation

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Ultrasonography
n=40 Participants
Patients requiring single lung ventilation for a surgical procedure will have a bedside ultrasound to evaluate lung isolation. Portable, Point-of-Care Ultrasound: Portable ultrasonography done at the bedside.
Age, Categorical
<=18 years
40 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
Age, Continuous
4.9 years
n=5 Participants
Sex: Female, Male
Female
17 Participants
n=5 Participants
Sex: Female, Male
Male
23 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
Race (NIH/OMB)
White
0 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
40 Participants
n=5 Participants
Region of Enrollment
United States
40 participants
n=5 Participants
Weight (kg)
18.0 kilograms
n=5 Participants
Height (cm)
106 centimeters
n=5 Participants
ASA physical status
ASA I
1 Participants
n=5 Participants
ASA physical status
ASA II
12 Participants
n=5 Participants
ASA physical status
ASA III
25 Participants
n=5 Participants
ASA physical status
ASA IV
2 Participants
n=5 Participants
Technique for one lung ventilation (OLV)
Double-lumen tube
16 Participants
n=5 Participants
Technique for one lung ventilation (OLV)
Bronchial blocker
5 Participants
n=5 Participants
Technique for one lung ventilation (OLV)
Bronchial intubation
19 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Within 5 minutes of intubation and single lung ventilation device placement

Ultrasound will be used to look for lung sliding in the ventilated lung field and lack of lung sliding and presence of lung pulse on the operative/isolated lung field. The effectiveness of this modality will also be compared to the lung auscultation for assessing lung isolation, which along with FOB is the current accepted standards of care.

Outcome measures

Outcome measures
Measure
Ultrasonography
n=40 Participants
Patients requiring single lung ventilation for a surgical procedure will have a bedside ultrasound to evaluate lung isolation. Portable, Point-of-Care Ultrasound: Portable ultrasonography done at the bedside.
Auscultation
n=40 Participants
Patients requiring single lung ventilation for a surgical procedure will have auscultation via stethoscope to evaluate lung isolation.
The Accuracy of Using Ultrasound to Assess Lung Isolation by Visualizing Lung Movement or Lack Thereof of Both the Operative and Non-operative Lung Fields.
Sensitivity
97 percent
Interval 83.4 to 99.9
65 percent
Interval 46.5 to 79.7
The Accuracy of Using Ultrasound to Assess Lung Isolation by Visualizing Lung Movement or Lack Thereof of Both the Operative and Non-operative Lung Fields.
Specificity
67 percent
Interval 12.5 to 98.2
100 percent
Interval 31.0 to 100.0
The Accuracy of Using Ultrasound to Assess Lung Isolation by Visualizing Lung Movement or Lack Thereof of Both the Operative and Non-operative Lung Fields.
Accuracy
95 percent
Interval 82.7 to 98.5
68 percent
Interval 51.5 to 80.4
The Accuracy of Using Ultrasound to Assess Lung Isolation by Visualizing Lung Movement or Lack Thereof of Both the Operative and Non-operative Lung Fields.
Positive predictive value (PPV)
97 percent
Interval 83.4 to 99.9
100 percent
Interval 81.5 to 100.0
The Accuracy of Using Ultrasound to Assess Lung Isolation by Visualizing Lung Movement or Lack Thereof of Both the Operative and Non-operative Lung Fields.
Negative predictive value (NPV)
67 percent
Interval 12.5 to 98.2
20 percent
Interval 5.3 to 48.6

PRIMARY outcome

Timeframe: Within 5 minutes of intubation and single lung ventilation device placement

Compare the time required to confirm lung isolation using auscultation, fiberoptic bronchoscopy (FOB), and ultrasound.

Outcome measures

Outcome measures
Measure
Ultrasonography
n=40 Participants
Patients requiring single lung ventilation for a surgical procedure will have a bedside ultrasound to evaluate lung isolation. Portable, Point-of-Care Ultrasound: Portable ultrasonography done at the bedside.
Auscultation
Patients requiring single lung ventilation for a surgical procedure will have auscultation via stethoscope to evaluate lung isolation.
Time to Confirm Lung Isolation
Total auscultation time
21 seconds
Interval 10.0 to 32.0
Time to Confirm Lung Isolation
Total FOB time
179 seconds
Interval 91.0 to 241.0
Time to Confirm Lung Isolation
Total ultrasound time
67 seconds
Interval 46.0 to 142.0

Adverse Events

Ultrasonography

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Alok Moharir

Nationwide Children's Hospital

Phone: 614-722-4200

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place